PLX4720

News alerts, weekly reports and conference planners

Company:

Daiichi Sankyo

Drug class:

BRAF inhibitor

Related drugs:

miR-340 expression	Thyroid Gland Carcinoma	miR-340 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-361 expression	Thyroid Gland Carcinoma	miR-361 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-363 expression	Thyroid Gland Carcinoma	miR-363 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-3651 expression	Thyroid Gland Carcinoma	miR-3651 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-3917 expression	Thyroid Gland Carcinoma	miR-3917 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-409 expression	Thyroid Gland Carcinoma	miR-409 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-4467 expression	Thyroid Gland Carcinoma	miR-4467 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-4473 expression	Thyroid Gland Carcinoma	miR-4473 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-449c expression	Thyroid Gland Carcinoma	miR-449c expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-425 expression	Thyroid Gland Carcinoma	miR-425 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-4664 expression	Thyroid Gland Carcinoma	miR-4664 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-4745 expression	Thyroid Gland Carcinoma	miR-4745 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-504 expression	Thyroid Gland Carcinoma	miR-504 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-543 expression	Thyroid Gland Carcinoma	miR-543 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-584 expression	Thyroid Gland Carcinoma	miR-584 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-660 expression	Thyroid Gland Carcinoma	miR-660 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-664a expression	Thyroid Gland Carcinoma	miR-664a expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-7 expression	Thyroid Gland Carcinoma	miR-7 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-760 expression	Thyroid Gland Carcinoma	miR-760 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-92a-1 expression	Thyroid Gland Carcinoma	miR-92a-1 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-424 expression	Thyroid Gland Carcinoma	miR-424 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-100 expression	Thyroid Gland Carcinoma	miR-100 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-1293 expression	Thyroid Gland Carcinoma	miR-1293 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-96 expression	Thyroid Gland Carcinoma	miR-96 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-99a expression	Thyroid Gland Carcinoma	miR-99a expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-320a expression	Thyroid Gland Carcinoma	miR-320a expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-490 expression	Thyroid Gland Carcinoma	miR-490 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
BRAF V600E	Melanoma	BRAF V600E	Melanoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-769 expression	Thyroid Gland Carcinoma	miR-769 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
BRAF V600E	Astrocytoma	BRAF V600E	Astrocytoma	palbociclib + PLX4720 Sensitive: D – Preclinical palbociclib + PLX4720 Sensitive : D	palbociclib + PLX4720 Sensitive: D – Preclinical palbociclib + PLX4720 Sensitive : D
BRAF V600E	Astrocytoma	BRAF V600E	Astrocytoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
BRAF mutation	Colorectal Cancer	BRAF mutation	Colorectal Cancer	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D

PLX4720

Associations
(65)

Associations
(65)

PLX4720

Associations(65)

Associations(65)

Associations
(65)

Associations
(65)